Abstract
Malignant diffuse mesothelioma is characterized by more difficult diagnosis and worse prognosis than other pleural tumors. In the Department of Thoracic Surgery, Hyogo Medical Center for Adults, 11 patients underwent panpleuropneumonectomy for this disease between January, 1988 and March, 1993. In 7 of these cases, Ga-67 scans were obtained before the operation.
To clarify the factors affecting Ga-67 uptake in the pleural tumor, we compared Ga-67 uptake on the involved side of the thorax with CT and the pathological findings of the tumor. Regarding the use of Ga-67 scan imaging for the diagnosis of this disease, a number of related findings must be considered, such as an encircled wide Ga-67 uptake in the thickened pleural involvement and a diffuse slight Ga-67 uptake on the affected side with very slight involvement of the pleura. When the involved pleural thickness was over 6 mm, a definite correlation was found between the degree of Ga-67 uptake and the macroscopic thickness of mesothelioma in resected specimens. Thickness of the pleura on CT images demonstrates the real tumor thickness in the case of thickened involvement but in the case of thin involvement the real thickness of active mesothelioma could not be identified. No definite correlation was found between the degree of Ga-67 uptake and the histological type, or among microscopic findings, such as the extent of tumor parenchyma, interstitial volume and tumor vascularity.
Our results suggest that the Ga-67 scan is very useful for revealing the extent of pleural involvement, especially when this involvement is more than 6 mm thick.
Similar content being viewed by others
References
Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothelioma of the pleura. Review of 123 patients.Cancer 49: 2431–2435, 1982.
Rusch VW, Godwin JD, Shuman WP. The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma.J Thorac Cardiovasc Surg 96: 171–177, 1988.
Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases.AJR 155: 965–969, 1990.
Patz EF, Shaffer K, Piwnica-Worms DR, Jochelson M, Sarin M, Sugarbaker DJ, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.AJR 159: 961–966, 1992.
Metintas M, Ozdemir N, Isiksoy S, Kaya T, Ekici M, Erginel S, et al. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma.J Comput Assist Tomogr 19: 370–374, 1995.
Nakano T, Fujii J, Tamuro S, Amuro Y, Nabeshima K, Horai T, et al. Glycosaminoglycan in malignant pleural mesothelioma.Cancer 57: 106–110, 1986.
Wolk RB. Gallium-67 scanning in the evaluation of mesothelioma.J Nucl Med 19: 808–809, 1978.
Seo IS, Joo KG, Carter JE. Demonstration of pleural mesothelioma by gallium scan.Clin Nucl Med 5: 407–409, 1980.
Nakano T, Maeda J, Iwahashi N, Tamura S, Hada T, Higashino K. Gallium-67 scanning in patients with malignant pleural mesothelioma.Jpn J Med 29: 255–260, 1990.
Shinkai T, Imai T, Nishimoto Y, Tsushima J, Otsuji H, Ohishi H, et al. Clinical evaluation of malignant mesothelioma with Ga-67, Tl-201 scintigraphy.Rinsho Hoshasen-Japanese Journal of Clinical Radiology 43: 55–63, 1998.
Da Valle MJ, Faber LP, Kittle CF, Jensik RJ. Extrapleural pneumonectomy for diffuse malignant mesothelioma.Ann Thorac Surg 42: 612–618, 1986.
Ginsberg RJ. Diffuse malignant mesothelioma. A therapeutic dilemma.Ann Thorac Surg 42: 608, 1986.
Rusch VW. Diagnosis and treatment of pleural mesothelioma.Semin Surg Oncol 6: 279–285, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshida, S., Fukumoto, M., Motohara, T. et al. Ga-67 tumor scan in malignant diffuse mesothelioma —Comparison with CT and pathological findings—. Ann Nucl Med 13, 49–54 (1999). https://doi.org/10.1007/BF03165429
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03165429